|
COPYRIGHT 2002 PR Newswire Association LLC
Genta Incorporated today announced its participation at the JP Morgan H&Q Healthcare Conference in San Francisco, CA. Raymond P. Warrell, Jr., M.D., Chairman and Chief Executive Officer, will make a presentation on Monday, January 6, 2003 at 2:30 p.m. PST that will feature clinical overviews and updates on the Company's Genasense(TM) (oblimersen sodium) and Ganite(R) (gallium nitrate) programs.
The webast of the presentation can be accessed via the web through Genta's investor site at: http://genta.com/investor/events.htm . A replay will be available for 30 days following the presentation.
About Genasense
Genasense works by inhibiting the production of Bcl-2, a protein made by cancer cells that is thought to block...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
